Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
| Last: | $0.235 |
|---|---|
| Change Percent: | 5.1% |
| Open: | $0.2166 |
| Close: | $0.2236 |
| High: | $0.235 |
| Low: | $0.2161 |
| Volume: | 68,143 |
| Last Trade Date Time: | 02/27/2026 12:41:08 pm |
| Market Cap: | $1,720,009 |
|---|---|
| Float: | 6,703,359 |
| Insiders Ownership: | N/A |
| Institutions: | 1 |
| Short Percent: | N/A |
| Industry: | Medical Diagnostics & Screening |
| Sector: | Healthcare |
| Website: | https://www.viraxbiolabs.com |
| Country: | GB |
| City: | Lanarkshire |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Virax Biolabs Group Limited (NASDAQ: VRAX).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
